GeneReach Biotechnology vs DaBomb Protein Biotech: monthly revenue

Monthly revenue and year-on-year change for GeneReach Biotechnology (4171) and DaBomb Protein Biotech (6578) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ GeneReach Biotechnology ━ DaBomb Protein Biotech

0%+97%-45%25/1026/0126/0426/0726/10

Monthly revenue history

MonthGeneReach BiotechnologyYoYDaBomb Protein BiotechYoY
Oct 2026NT$21.7 million+12.3%NT$40.1 million+45.4%
Sep 2026NT$15 million-20.0%NT$34.6 million+29.7%
Aug 2026NT$18.2 million+6.2%NT$34 million+97.4%
Jul 2026NT$23.3 million+32.9%NT$37.7 million+50.4%
Jun 2026NT$22 million+27.3%NT$35.2 million+35.8%
May 2026NT$17.8 million-0.6%NT$35.9 million+27.2%
Apr 2026NT$20.2 million+4.7%NT$36.4 million-1.0%
Mar 2026NT$21.6 million+15.8%NT$34 million+24.0%
Feb 2026NT$13.6 million-44.7%NT$22.3 million+40.0%
Jan 2026NT$17.1 million+84.9%NT$25.8 million+2.1%
Dec 2025NT$30.4 million+56.0%NT$28.9 million+74.7%
Nov 2025NT$22.6 million+11.9%NT$24.5 million-30.2%
Oct 2025NT$19.3 million+26.8%NT$27.6 million-8.4%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16